Ginsenoside Rb1 has been shown to reverse neuroinflammation in the Aβ ICV injection-induced AD Wistar rat model by reducing the expression of COX-2, IkB-α, neuronal nitric oxide synthase (nNOS), and Aβ1-42 [167]. The gene discussed is PTGS2; the disease is Alzheimer disease.